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Palliative care in gynaecologic oncology focuses on specific and severe symp-
toms resulting from affected abdominal and pelvic organs and feminine genitals. 
These symptoms are mainly connected to advanced gynaecologic malignancies. 
Patients with locally advanced or recurrent gynaecologic cancers may present with 
various symptoms. Among those we discuss vaginal bleeding, vaginal discharge 
and fistulas. Vice versa non-malignant diseases and non-pelvic site diseases such 
as inflammations, overdose of anticoagulants, wounds or pressure ulcers may have 
similar clinical manifestation. Some symptoms may result from aggressive cancer 
treatment (oncological surgery, radiotherapy) with curative intent. Some symptoms 
get worse on account of the postmenopausal status (natural or artificial following 
any type of ovarian failure). For advanced gynae-oncological diseases it has been in 
practise, that the best palliative care is offered and practised simultaneously with 
curative treatment. The problematics of gynaecologic symptoms in palliative care 
represents delicate and intimate sphere and it may disturb patient’s autonomy and 
dignity. The mission of physicians, nurses and caregivers is to consider treatment 
options thoroughly in context of patient’s quality of life, prognosis and life condi-
tions to fulfil the ideals of the best symptomatic and supportive care.
Keywords: gynaecologic malignancies, vaginal bleeding, fistula, vaginal packing, 
embolisation
1. Introduction
Our contribution to the open access book of palliative care focuses on specific 
and severe symptoms resulting from affected abdominal and pelvic organs and 
feminine genitals. These symptoms are mainly connected to advanced gynae-
cologic malignancies. Patients with locally advanced or recurrent gynaecologic 
cancers may present with various symptoms. Among those we discuss vaginal 
bleeding, vaginal discharge and fistulas. Problematics of pain control, oedema and 
ascites, nausea and vomiting, shortness of breath and malignant bowel obstruction 
is common to most incurable advanced diseases and these are not connected to pel-
vic diseases only, see specific chapters. Vice versa non-malignant diseases and non-
pelvic site diseases such as inflammations, overdose of anticoagulants, wounds 
or pressure ulcers may have similar clinical manifestation. Some symptoms may 
result from aggressive cancer treatment (oncological surgery, radiotherapy) with 
curative intent. Some symptoms get worse on account of the postmenopausal 
status (natural or artificial following any type of ovarian failure). For advanced 
gynae-oncological diseases it has been in practise, that the best palliative care is 
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offered and practised simultaneously with curative treatment. Optimum palliative 
care can only be provided by a team that may include a gynaecologic oncologist, 
a radiation oncologist, an interventional radiologist, a palliative care physician, 
nurse and a social worker to address the various problems faced by these patients 
[1, 2]. All described clinical situations can be well solved in hospices as well as 
at patient’s home with the guidance of experienced mobile palliative care teams. 
Except for malignant bowel obstruction and severe genital bleeding, which both 
present extreme mental and physical load for the caregivers who witness it and it 
can be traumatizing experience for unprepared family members and healthcare 
providers.
2. Genital bleeding
Vaginal bleeding or discharge is the most common presenting symptom of 
advanced or recurrent gynaecologic malignancy. Patients may initially ignore bleed-
ing if it is minimal and potentially attributable to menses. However, direct invasion 
of blood vessels by tumour may come to cause massive bleeding. If it is beneficial 
for the patient, the source of the bleeding should be determined and solved accord-
ing to the possibilities (see Table 1). By that we mean no painful and stressing 
diagnostic procedures with preterminal and terminal patients. Initial management 
of pathologic vaginal bleeding requires a proper gynaecologic examination and 
considerations of placement of tight vaginal packing with haemodynamic support 
[1, 2]. The packing should be left in place for 24–48 hours maximum and then it 
must be extracted or replaced. Tight packing requires insertion of urinary catheter, 
because of urethral obstruction caused by packing. Prolonged packing in risky for 
severe inflammatory complications and fistula formation.
The aspect to consider is quality of life (relief of symptoms of anaemia versus 
reasonable and ethical protraction of suffering in conditions of incurable terminal 
status). Severe unaffected haemorrhage as the final event is really traumatizing for 
witnessing family members [1]. It should be well communicated in advance and if 
family members or caregivers do not feel comfortable with this situation, then it is 
better to evaluate the option of hospitalization in hospice.
In case of clinical status unresponsive to aggressive intervention, in exhausted 
terminal patients with severe uncontrollable vaginal haemorrhage, palliative seda-
tion is an ethically and morally appropriate option [3].
In all other cases that are not regarded as terminal phase of incurable disease, 
it is useful to try to affect blood loss. Mucosal haemorrhage usually does not 
have any haemodynamic impact and it is rather an annoying symptom. Often it 
becomes a side effect of anticoagulation as a prevention of thromboembolic event 
in advanced oncologic disease. In that case it should be balanced which situation is 
more comfortable for the patient (mucosal bleeding or risk of thromboembolism). 
The same type of mucosal bleeding is typical for radiotherapeutic toxicity (early 
and late onset effect) especially in combination with postmenopausal atrophy of 
the affected tissues. Also, any type of inflammation of atrophic mucosa may lead 
to mucosal haemorrhage. Frequent showering, rinsing or irrigating with disinfec-
tant solutions (betadine solution of maximum 10% concentration, chlorhexidine 
solution in commercially available remedies) is useful for both cases of mucosal 
bleeding, as well as trophy supporting creams (containing vitamin E). We highly 
recommend patient, family members and caregivers to pay attention to the best 
possible hygiene and skincare of genitals and frequent replacement of incontinence 
aids (pads, panties, diapers).
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Bleeding from tumour surfaces or as a consequence of direct invasion of blood 
vessels usually represents a stressful situation. It may lead to hypotension, tachycar-
dia, shortness of breath and disorders of consciousness. If it is in the patient’s inter-
est, and it does not interfere with quality - of life approach, it is possible to try to 
affect this type of bleeding by interventional radiology- based embolization (occlu-
sion of the vessels that are supplying the anatomic sites of uncontrolled bleeding - 
internal iliac arteries via femoral artery) [1, 2, 4]. In theory, the same procedure can 
be managed by open surgery or laparoscopically by ligation of internal iliac arteries. 
Profit of such a risky step is questionable (aspects of the surgery - wounds, addi-
tional blood loss, anaesthesia). The effect of internal iliac obstruction comes almost 
immediately, in hours and days we can observe decrease in blood loss.
Other option how to reduce vessel bleeding is palliative radiotherapy (external 
beam radiation therapy -EBRT and/or in combination with brachytherapy). The 
effect of irradiation evolves in days and week. A summary of literature suggests 
that the most commonly described fractionation scheme for these patients is 10Gy 
repeated at one-month intervals to a total of 30Gy as clinical circumstances dictate 
Source of 
haemorrhage
Possible etiology Options for treatment
Vulvar bleeding Inflammation in the conditions 
of atrophic skin and mucosa. 
Pressure ulcers
Malignant and non - malignant 
tumours
Antibiotic/antimycotic ointment, frequent 
showering.
For bleeding ulcers topical adrenalin, Monsel 
solution, and pressure bandage.
Palliative radiotherapy in malignant affections
Vaginal bleeding Vaginal, cervical and uterine 
malignant tumours of primary 
and secondary origin.
Fistulas vesico- and recto/
entero-vaginal.
Overdosing of anticoagulants.
Atrophic mucosa in combination 
with inflammation or post - 
radiotherapeutic status.
First aid method – vaginal packing.
For cervical and pelvic tumours interventional 
radiology – based embolization.
Evaluation of anticoagulant therapy, 
adjustments of the dosage in the case of 
palliative approach.
External radiotherapy (brachy−/external)
Urethral bleeding Urinary inflammation
Fistulas
Bladder infiltration
Post- radiotherapeutic atrophic 
mucosa
Overdosing of anticoagulants
Antibiotics and anti-inflammatory drugs
External palliative radiotherapy in bladder 
infilration
Urinary catheters and antifibrinolytic drugs 
(tranexamic acid) intravenously or orally in 
case of radiotherapy-related bleeding.
Percutaneous nephrostomy tubes bilaterally 
in fistulas
Suprapubic catheter in urethral damage 
(surgical, tumorous)
Anal bleeding Haemorrhoidal affections with 
combination of inflammatory 
complications.
Malignant tumours of 





Radiotherapy related mucosal 
affections
For external annal affections of different 
origin: topical adrenalin, Monsel solution and 
packing.
Anti-inflammatory suppositories and 
ointments.
Pelvic external palliative radiotherapy for 
tumours in pelvis
Anticoagulant drugs administered orally or 
intravenously
Table 1. 
Sources of bleeding, possible origin and treatment options.
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and tolerance of the dosing allows. Patients who receive all 3 fractions have superior 
outcomes compared to those who do not, though those with the longest survival 
often face a recurrence of their local symptoms and an increased incidence of severe 
toxicity. It is therefore prudent to consider a lower dose-per-fraction for patients 
who may survive 10 to 12 months, or longer [2].
The duration of the effect of both mentioned procedures (interventional 
radiologist occlusion and palliative radiotherapy) depends on many factors (the 
progression rate of oncologic disease, coexistence of other comorbidities and the 
overall clinical status of the frail palliative patient).
If symptomatic anaemia occurs, it is a matter of discussion whether the treat-
ment with blood transfusion is convenient. The benefits and disadvantages must 
be thoroughly evaluated, including economic aspects and availability of blood 
derivatives. Blood transfusion is questionable in the situation where severe bleed-
ing occurs with incurable progressive disease. According to the World Health 
Organisation (WHO) defines palliative care as a care that affirms life and regards 
dying as a natural process and intends neither to hasten nor postpone death. It also 
emphasizes impeccable assessment as essential for effective management [5].
Regardless of the context of the patient’s prognosis, quality of life and living 
conditions we always recommend: liquids orally or parenterally, parenteral antifi-
brinolytic medication if available, oxygen therapy, anxiolytic medication, morphine 
in the case of shortness of breath, and all other care known as the best symptomatic 
and supportive.
3. Fistulas
By the term fistula we mean pathologic communication between neighbouring 
organs, that does not normally (in conditions of healthy organism) exist. In patients 
with advanced progressive oncological diseases of pelvis, in patients after radical 
surgery +/− radiotherapy we often see vesico-vaginal and/or recto(entero-)vaginal 
fistulas as a consequence of super – radical curative approach. The presence of 
fistula leads to vaginal discharge, bleeding and develops to absolute urine and /or 
faecal incontinence. This problem has many aspects (physical, psychological, social, 
ethical), it has an overlap to the patient integrity and autonomy, especially concern-
ing women, mothers – the pillars of the families. This situation requires a delicate 
approach of the family members and caregivers. For treatment options see Table 2.
Because of all the above-mentioned overlaps of this upsetting symptom, the sur-
gical intervention comes always first. Surgical approach in not recommended only 
if the patient’s condition is poor and would not have any contributions to the quality 
of life by means of harm and stress It makes sense to solve fistulas and prevent 
Type of fistula Patient capable of surgical 
intervention
Patient uncapable of surgical 
intervention
Vesico - vaginal Abdominal/vaginal approach and 
reconstructive surgery
Bilateral nephrostomy
Urinary catheter, suprapubic catheter – 
partial relief
Continuous use of incontinence aids 
(pads, panties, diapers)
Recto - vaginal colostomy Incontinent aids
Entero - vaginal Enterostomy (small bowel) Incontinent aids
Table 2. 
Types of fistulas and treatment options in palliative patients.
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absolute incontinence even with immobile patients in otherwise good condition and 
low comorbidities.
In situations where fistulas cannot be bypassed, we stress again to focus on the 
hygiene and skincare (frequent change of incontinence pads, panties and diapers), 
showering genitals, disinfectant solutions (diluted betadine solution) rinsing and 
irrigating. Additionally, we recommend protective nutritive creams to prevent 
inflammation and pressure ulcers. Even when enterostomy or colostomy was 
constructed, some discharge from anus and/or vagina can appear, then the above 
mentioned also applies. The problem of the acidic intestinal content is, that it gets 
painful in contact with vaginal mucosa in contrast to urine, that is weakly acidic or 
neutral and usually does not cause any pain. Thus, with faecal incontinence good 
pain relief is required. If the construction of stomy is not possible and we deal with 
the situation of a terminal patient with poor prognosis the restriction in alimenta-
tion (feeding and eating) comes in question. Vice versa in case of a patient inca-
pable of surgical procedure but not in preterminal nor terminal status, parenteral 
nutrition should be considered. Otherwise, parenteral nutrition precedes surgical 
treatment at least for several days for the purpose to reduce the bowel content.
As for the comfort of the patient and the caregivers we recommend air washers, 
aroma diffusers, fanning or other air fresheners.
4. Vaginal discharge
Most of the causes of vaginal discharge in palliative patients were discussed in 
previous paragraphs. Evaluation of new discharge is always warning as it may stand 
for fungal or bacterial infection, which can be treated in the same way as in com-
mon gynaecology practise with local disinfectants, antibiotics and antimycotics, 
together with good hygiene and probiotic supplementation to reinstall the normal 
Type of discharge Etiology Treatment options
Inflammatory - purulent Vulvar, vaginal, 
urinary infection
Tumour growth
Disinfectant solutions (10% betadine solution, 
chlorohexidine solution et.)
Mycotic Dysmicrobia of 
genitalia
In diabetic and 
immobile patients
Antimycotics – suppositories, ointments, creams 
together with probiotics and frequent hygiene by 
showering and rinsing (including above mentioned 
disinfectants)







Urinary catheters, suprapubic catheters, surgical 
approach
Paracentesis for ascites derivation
Hygiene and skincare





Disinfectants, nutritive and protective creams
Surgery in fistulas if possible
Antifibrinolytics in medication
Vaginal packing in tumour bleeding
With faecal content Fistulas
Faecal incontinence
Surgical approach and/or best hygiene and skincare
Table 3. 
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microbial environment of vagina [1]. In those cases where the discharge represents 
disease progression (in addition with bleeding and fistulas), a plan for hygiene 
and for treatment options has to be collaboratively developed (considering surgery 
procedures, conservative approach, pain relief etc.). See Table 3.
5. Conclusion
The problematics of gynaecologic symptoms in palliative care that we discussed 
represents delicate and intimate sphere and it may disturb patient’s autonomy and 
dignity. The mission of physicians, nurses and caregivers is to consider treatment 
options thoroughly in context of patient’s quality of life, prognosis and life condi-
tions to fulfil the ideals of the best symptomatic and supportive care.
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